Covista CVSA
$109.13 −$6.38 (-5.52%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $109.13 0.00%
Open$115.17
Prev close$115.51
Day range$109.02 – $118.06
Volume462.8K
Market cap$3.63B
P/E (TTM)14.9
Dividend yield–
Fundamentals
Latest reported quarter: Q1, ended Sep 2026
Revenue$511.53M+10.7% YoY
Operating profit$98.19M+14.5% YoY
Net profit$67.43M+9.0% YoY
Diluted EPS$1.95+16.8% YoY
Free cash flow$76.45M-33.3% YoY
Operating cash flow$114.04M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin57.4%
Operating margin20.1%
Net margin12.8%
Return on equity17.9%
Return on assets8.9%
Return on invested capital12.8%
Current ratio0.81
Liabilities / assets51.5%
Cash & investments$222.22M
Total debt$719.61M
Net cash (debt)-$497.38M
Free cash flow / sales17.7%
Where the revenue comes from
Quarter 2027/Q1
By business line
Income statement
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $511.53M | $1.95B | $501.38M | $487.03M | $503.39M |
| Total Operating Revenue | $511.53M | $1.95B | $501.38M | $487.03M | $503.39M |
| Cost of Revenue | $220.76M | $833.66M | $216.75M | $210.72M | $205.43M |
| Gross Profit | $290.78M | $1.12B | $284.63M | $276.31M | $297.96M |
| Operating Expense | $192.59M | $730.72M | $188.09M | $184.11M | $182.79M |
| Selling and Admin Expenses | $192.59M | $730.72M | $188.09M | $184.11M | $182.79M |
| -General & Admin Expense | $192.59M | – | – | $184.11M | – |
| Operating Profit | $98.19M | $389.71M | $96.54M | $92.21M | $115.17M |
| Net Non-Operating Interest Income (Expense) | -$8.31M | -$39.98M | -$8.20M | -$13.15M | -$9.34M |
| Non-Operating Interest Income | $1.63M | $5.46M | $1.60M | $481,000.00 | $1.57M |
| Non-Operating Interest Expense | $8.79M | $39.16M | $8.32M | $12.08M | $9.62M |
| Total Other Finance Costs | $1.15M | $6.27M | $1.48M | $1.55M | $1.30M |
| Other Income (Expense) | -$381,000.00 | -$4.61M | $58,000.00 | -$1.11M | -$3.93M |
| Gain on Sale of Security | -$218,000.00 | $1.72M | $1.16M | -$249,000.00 | $130,000.00 |
| Special Income (Charges) | -$163,000.00 | -$6.33M | -$1.10M | -$863,000.00 | -$4.06M |
| -Less:Restructuring and Mergern & Acquisition | $163,000.00 | $6.33M | $1.10M | $863,000.00 | $4.06M |
| Pretax Profit | $89.50M | $345.12M | $88.40M | $77.95M | $101.90M |
| Tax | $18.02M | $77.74M | $16.24M | $19.96M | $25.73M |
| Net Profit | $67.43M | $251.57M | $71.72M | $41.64M | $76.38M |
| Profit from Continuing Operations | $71.48M | $267.38M | $72.16M | $57.98M | $76.17M |
| Net Income from Discontinuous Operations | -$4.06M | -$15.81M | -$439,000.00 | -$16.35M | $205,000.00 |
| Net Income to Parent Company | $67.43M | $251.57M | $71.72M | $41.64M | $76.38M |
| Net Income to Common Stockholders | $67.43M | $251.57M | $71.72M | $41.64M | $76.38M |
| Basic EPS | $1.99 | $7.18 | $2.11 | $1.21 | $2.14 |
| Diluted EPS | $1.95 | $7.04 | $2.06 | $1.20 | $2.11 |
| Dividend Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance sheet
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Total Assets | $2.93B | $3.01B | $3.01B | $2.74B | $2.61B |
| Total Current Assets | $552.57M | $652.44M | $652.44M | $403.76M | $302.98M |
| Cash and Cash Equivalents & Short-Term Investments | $222.22M | $406.32M | $406.32M | $146.98M | $56.28M |
| -Cash and Cash Equivalents | $222.22M | $406.32M | $406.32M | $146.98M | $56.28M |
| Receivables | $241.47M | $169.56M | $169.56M | $175.92M | $162.85M |
| -Accounts Receivable | $241.47M | $169.56M | $169.56M | $175.92M | $162.85M |
| Restricted Cash | $2.34M | $1.44M | $1.44M | $1.86M | $2.36M |
| Other Current Assets | $86.54M | $75.13M | $75.13M | $78.99M | $81.49M |
| Total Non-Current Assets | $2.38B | $2.36B | $2.36B | $2.33B | $2.31B |
| Net PPE | $522.22M | $507.01M | $507.01M | $478.05M | $455.52M |
| -Gross PPE | $915.41M | $889.97M | $889.97M | $850.50M | $816.76M |
| -Accumulated Depreciation | -$393.19M | -$382.96M | -$382.96M | -$372.45M | -$361.24M |
| Goodwill and Other Intangible Assets | $1.71B | $1.72B | $1.72B | $1.72B | $1.72B |
| -Goodwill | $961.26M | $961.26M | $961.26M | $961.26M | $961.26M |
| -Other Intangible Assets | $752.86M | $754.25M | $754.25M | $757.06M | $759.86M |
| Other Non-Current Assets | $139.36M | $137.74M | $137.74M | $137.30M | $135.09M |
| Total Liabilities | $1.51B | $1.57B | $1.57B | $1.37B | $1.24B |
| Total Current Liabilities | $684.50M | $596.82M | $596.82M | $580.45M | $442.89M |
| Payables | $96.38M | $124.76M | $124.76M | $97.26M | $103.10M |
| -Accounts Payable | $96.38M | $124.76M | $124.76M | $97.26M | $103.10M |
| Current Accrued Expenses | $183.93M | $173.03M | $173.03M | $167.94M | $125.44M |
| Short-Term Debt and Capital Lease Obligation | $39.08M | $39.90M | $39.90M | $39.06M | $33.92M |
| -Current Debt | $5.10M | $5.10M | $5.10M | $3.83M | – |
| -Current Capital Lease Obligation | $33.98M | $34.80M | $34.80M | $35.23M | $33.92M |
| Current Deferred Liabilities | $365.10M | $259.13M | $259.13M | $276.19M | $180.43M |
| Total Non-Current Liabilities | $822.13M | $969.70M | $969.70M | $792.88M | $793.03M |
| Long Term Debt and Capital Lease Obligation | $714.51M | $865.60M | $865.60M | $697.24M | $695.64M |
| -Long Term Debt | $495.13M | $657.75M | $657.75M | $495.64M | $504.28M |
| -Long Term Capital Lease Obligation | $219.37M | $207.85M | $207.85M | $201.60M | $191.35M |
| Non-Current Deferred Liabilities | $69.32M | $61.78M | $61.78M | $58.73M | $56.82M |
| Other Non-Current Liabilities | $38.31M | $42.33M | $42.33M | $36.91M | $40.58M |
| Total Equity | $1.42B | $1.45B | $1.45B | $1.36B | $1.38B |
| Stockholders' Equity | $1.42B | $1.45B | $1.45B | $1.36B | $1.38B |
| Capital Stock | $851,000.00 | $848,000.00 | $848,000.00 | $847,000.00 | $847,000.00 |
| -Common Stock | $851,000.00 | $848,000.00 | $848,000.00 | $847,000.00 | $847,000.00 |
| Additional Paid-In Capital | $715.49M | $706.91M | $706.91M | $696.47M | $686.59M |
| Retained Earnings | $3.10B | $3.03B | $3.03B | $2.96B | $2.92B |
| Less: Treasury Stock | -$2.39B | -$2.29B | -$2.29B | -$2.29B | -$2.22B |
| Gains/Losses Not Affecting Retained Earnings | -$2.23M | -$2.23M | -$2.23M | -$2.23M | -$2.23M |
| Non-Current Deferred Assets | – | $0.00 | $0.00 | $0.00 | $0.00 |
Cash flow
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Operating Cash Flow | $114.04M | $470.42M | $123.96M | $186.17M | $29.74M |
| Net cash flow from continuing operations | $114.27M | $470.80M | $124.38M | $186.30M | $29.48M |
| Net Income from Continuing Operations | $71.48M | $267.38M | $72.16M | $57.98M | $76.17M |
| Gain/Loss from Continuing Operations | $218,000.00 | -$977,000.00 | -$1.02M | $850,000.00 | -$128,000.00 |
| Depreciation & Depletion & Amortization | $19.27M | $83.02M | $20.97M | $20.78M | $20.95M |
| Deferred Tax | $8.80M | $68.35M | $3.03M | $7.40M | $3.50M |
| Other Non-Cash Items | $660,000.00 | $7.62M | $660,000.00 | $4.41M | $1.41M |
| Change in Working Capital | -$16.74M | -$64.57M | -$1.45M | $67.89M | -$102.21M |
| -Change in Receivables | -$94.22M | -$89.26M | -$12.99M | -$29.55M | $15.97M |
| -Change in Prepaid Assets | -$10.79M | $8.42M | $9.32M | $2.53M | $26.41M |
| -Change in Payables and Accrued Expense | -$21.40M | -$1.01M | $22.90M | $8.02M | $3.34M |
| -Change in Other Current Assets | -$3.29M | -$13.95M | -$3.87M | -$2.96M | -$2.32M |
| -Change in Other Current Liabilities | $10.55M | -$19.80M | -$4.41M | -$6.63M | -$4.44M |
| -Change In Other Working Capital | $102.40M | $51.04M | -$12.40M | $96.48M | -$141.16M |
| Cash Flow from Discontinued Operating Activities | -$233,000.00 | -$374,000.00 | -$419,000.00 | -$135,000.00 | $260,000.00 |
| Net cash flow from investing | -$37.59M | -$83.70M | -$27.82M | -$20.24M | -$19.62M |
| Net Cash Flow from Continuing Investing Activities | -$37.59M | -$83.70M | -$27.82M | -$20.24M | -$19.62M |
| Capital Expenditure | -$37.59M | -$77.70M | -$26.81M | -$20.24M | -$14.62M |
| Net Investment Purchase and Sale | $0.00 | -$1.00M | -$1.01M | $0.00 | $1,000.00 |
| Financing Cash Flow | -$259.64M | -$180.13M | $162.77M | -$75.73M | -$217.67M |
| Net Cash Flow from Continuing Financing Activities | -$259.64M | -$180.13M | $162.77M | -$75.73M | -$217.67M |
| Net Issuance Payments Of Debt | -$163.00M | $112.17M | $163.00M | -$833,000.00 | -$50.00M |
| Net Common Stock Issuance | -$81.00M | -$239.87M | $0.00 | -$67.50M | -$164.77M |
| Proceeds from Stock Option Exercised | $564,000.00 | $1.92M | $485,000.00 | $490,000.00 | $404,000.00 |
| Net Other Financing Charges | -$16.20M | -$54.35M | -$714,000.00 | -$7.89M | -$3.30M |
| Ending Cash Balance | $224.56M | $407.75M | $407.75M | $148.84M | $58.64M |
| Net Change in Cash | -$183.20M | $206.59M | $258.92M | $90.20M | -$207.55M |
| Beginning Cash Balance | $407.75M | $201.16M | $148.84M | $58.64M | $266.19M |
| Free Cash Flow | $76.45M | $392.73M | $97.15M | $165.93M | $15.12M |
| Net Business Purchase and Sale | – | -$5.00M | $0.00 | $0.00 | – |
No comments yet — be the first to weigh in on CVSA.
Sign in to join the discussion.